rs41306974
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000527.5(LDLR):c.2312-47G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,549,938 control chromosomes in the GnomAD database, including 165 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 14 hom., cov: 31)
Exomes 𝑓: 0.013 ( 151 hom. )
Consequence
LDLR
NM_000527.5 intron
NM_000527.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.749
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-11127961-G-A is Benign according to our data. Variant chr19-11127961-G-A is described in ClinVar as [Benign]. Clinvar id is 252278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11127961-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0112 (1699/152138) while in subpopulation NFE AF = 0.0173 (1173/67986). AF 95% confidence interval is 0.0164. There are 14 homozygotes in GnomAd4. There are 810 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 14 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.2312-47G>A | intron_variant | Intron 15 of 17 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0112 AC: 1700AN: 152020Hom.: 14 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1700
AN:
152020
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0104 AC: 2612AN: 250328 AF XY: 0.0106 show subpopulations
GnomAD2 exomes
AF:
AC:
2612
AN:
250328
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0132 AC: 18435AN: 1397800Hom.: 151 Cov.: 25 AF XY: 0.0131 AC XY: 9154AN XY: 699180 show subpopulations
GnomAD4 exome
AF:
AC:
18435
AN:
1397800
Hom.:
Cov.:
25
AF XY:
AC XY:
9154
AN XY:
699180
Gnomad4 AFR exome
AF:
AC:
72
AN:
32140
Gnomad4 AMR exome
AF:
AC:
411
AN:
44646
Gnomad4 ASJ exome
AF:
AC:
320
AN:
25784
Gnomad4 EAS exome
AF:
AC:
2
AN:
39378
Gnomad4 SAS exome
AF:
AC:
384
AN:
85024
Gnomad4 FIN exome
AF:
AC:
398
AN:
52098
Gnomad4 NFE exome
AF:
AC:
16164
AN:
1054932
Gnomad4 Remaining exome
AF:
AC:
639
AN:
58146
Heterozygous variant carriers
0
980
1959
2939
3918
4898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0112 AC: 1699AN: 152138Hom.: 14 Cov.: 31 AF XY: 0.0109 AC XY: 810AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
1699
AN:
152138
Hom.:
Cov.:
31
AF XY:
AC XY:
810
AN XY:
74362
Gnomad4 AFR
AF:
AC:
0.00240859
AN:
0.00240859
Gnomad4 AMR
AF:
AC:
0.0154754
AN:
0.0154754
Gnomad4 ASJ
AF:
AC:
0.0132488
AN:
0.0132488
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00353137
AN:
0.00353137
Gnomad4 FIN
AF:
AC:
0.00876862
AN:
0.00876862
Gnomad4 NFE
AF:
AC:
0.0172536
AN:
0.0172536
Gnomad4 OTH
AF:
AC:
0.0146641
AN:
0.0146641
Heterozygous variant carriers
0
82
164
247
329
411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypercholesterolemia, familial, 1 Benign:1
Mar 25, 2016
LDLR-LOVD, British Heart Foundation
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:literature only
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=99/1
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at